FORMULATION OPTIMIZATION FOR VIRAL PARTICLES
The present disclosure provides formulations for maintaining viral particles in a stable form. In certain embodiments, the formulation comprises at least one basic amino acid and a buffer solution, wherein the viral particle is present at a concentration of about 1×1011 to about 5×1013 DNase resista...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure provides formulations for maintaining viral particles in a stable form. In certain embodiments, the formulation comprises at least one basic amino acid and a buffer solution, wherein the viral particle is present at a concentration of about 1×1011 to about 5×1013 DNase resistant virus particles per mL. |
---|